Awaiting product image

Article: Daratumumab news at EHA 2019: promising results in transplant-eligible multiple myeloma patients and a more convenient subcutaneous drug formulation

€3.03

SKU: product-article-14110 Category:

Description

Daratumumab news at EHA 2019: promising results in transplant-eligible multiple myeloma patients and a more convenient subcutaneous drug formulation

Reviews

There are no reviews yet.

Be the first to review “Article: Daratumumab news at EHA 2019: promising results in transplant-eligible multiple myeloma patients and a more convenient subcutaneous drug formulation”

Related products